Literature DB >> 7923336

[Long-term efficacy of hepatitis B vaccine in newborn and revaccination study].

H Cheng1, Z Guo, Y Zhang.   

Abstract

Two-hundred and sixty-nine newborns were followed up for 4 and 5 years after completion of vaccination (10 micrograms x 3). The anti-HBs positive rates remained 82.54% and 72.03%, respectively. The low-level titer (> or = 10-99 mIU/ml) made up 44.61%, and the medium-level titer (> or = 100-99mIU/ml) 32.34%. The highest titer was 857 mIU/ml. A 10 micrograms dose of hepatitis B vaccine was given to these children. The anti-HBs level went up greatly in the first month after revaccination, but started to drop in the third month, decreased rapidly in the sixth month, and in the twelveth month the level trended to restore the level before revaccination. This paper indicated that the home-made hepatitis B vaccine was effective. Revaccination was not necessary within 5-7 years after initial vaccination. Revaccination to children whose anti-HBs level was < 10mIU/ml was beneficial but the anti-HBs persistence was short.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923336

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  1 in total

1.  Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization.

Authors:  Hui Li; Rong-Cheng Li; Su-Su Liao; Jin-Ye Yang; Xian-Jia Zeng; Shu-Sheng Wang
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.